The Drug Delivery to the Lungs (DDL) Conference is a leading international forum dedicated to pulmonary and nasal drug delivery, bringing together a diverse audience including researchers, industry professionals, clinicians, and regulators. It features a robust program of lectures, poster sessions, an industry exhibition, and dedicated opportunities to support and highlight work by early-career scientists.

Date: December 11-12, 2025
Location: Edinburgh, Scotland
Booth: #195

JOIN US!

Catalent Inhalation has the capabilities, expertise, and state-of-the-art facilities to expedite product development, from concept and feasibility studies through commercial manufacture and release testing. Complete the form to schedule a meeting with the Catalent Inhalation team at DDL 2025 to discuss how we can partner and help bring your inhaled therapy to market, faster.

Complete the form to schedule a meeting with our experts.

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™